A partner at a mid-sized VC fund told me recently that his team was drowning in deal flow — 400+ inbounds a quarter, two junior analysts, and a mandate to not miss the next breakout company. Six months later, after weaving AI into their pipeline, they’d cut first-pass screening time by 70% and were spending more actual human hours on the deals that deserved it. That’s not a pitch deck stat. That’s the specific, unglamorous reality of what AI is doing for investors right now.
This isn’t about replacing the judgment call — the gut-check lunch, the founder reference call, the read on whether someone will push through a bad quarter. That still lives with humans. What’s changed is everything upstream of that: the research, the pattern-matching, the signal extraction from noisy data, the competitive mapping. AI is compressing weeks of analyst work into hours, and the investors who’ve figured out the workflow are operating at a different speed than those who haven’t.
Here’s how it actually works in practice.
The Deal Screening Problem AI Actually Solves
Most investment teams don’t fail because they made a bad bet. They fail because they missed a good one — buried in a spreadsheet, lost in an email thread, or simply never evaluated because there weren’t enough hours. AI attacks this specific bottleneck.
The workflow that’s gaining traction at early-stage funds looks something like this: a pitch deck or company brief comes in, gets fed to a large language model (GPT-4o, Claude 3.5 Sonnet, or Gemini 1.5 Pro are the current workhorses), and the model is prompted against a custom investment thesis framework. The output isn’t a decision — it’s a structured memo. Market size estimate, comparable companies, obvious gaps in the pitch, questions the team should ask, and a flag on whether the deal fits the fund’s stated criteria.
Firms like Sequoia and a16z haven’t published their internal tooling, but the pattern is visible from the outside: faster turnaround, more structured diligence memos, and a growing appetite for AI-native portfolio companies that hints at teams who’ve already stress-tested these tools. Smaller funds are often moving faster — Signal Peak Ventures and Fika Ventures have both spoken publicly about building AI into their screening workflows.
The key insight is that AI doesn’t need to be right about whether a company will succeed. It needs to be good enough at filtering to make sure the human beings in the room are spending their limited attention on the right 10% of deal flow. That’s a much more achievable bar.
What Tools Are Actually Being Used
The tooling landscape breaks into a few distinct layers, and serious investors are typically pulling from all of them:
General-Purpose LLMs for Research and Synthesis
ChatGPT (OpenAI) — GPT-4o with the web browsing tool enabled has become a fast-draft research engine. You can drop in a company URL, a 10-K, or a earnings call transcript and get a structured synthesis in minutes. The operator-level tier (ChatGPT Team or Enterprise) adds persistent memory and better data handling. Pricing changes frequently — check OpenAI’s site for current tiers, but Team runs in the range of $25-30/user/month as of early 2026.
Claude (Anthropic) — Claude 3.5 Sonnet and the newer Claude 3.7 models are the current favorites for long-document analysis because of their large, reliable context windows. Feed it a full S-1 filing or a 200-page industry report and ask it to extract competitive positioning, risk factors, and financial inflection points. Anthropic’s Claude.ai Pro and Team tiers are worth checking for current pricing.
Perplexity Pro — Increasingly popular for real-time competitive research. Unlike a static LLM, Perplexity actively cites sources, which matters when you’re doing diligence and need to verify claims. The Pro tier adds access to GPT-4o and Claude within the same interface. Around $20/month as of early 2026.
Specialized Fintech and Data Intelligence Tools
AlphaSense — Enterprise-grade, used heavily by hedge funds and larger institutional investors. Its AI search layer runs across earnings calls, broker research, regulatory filings, and news — and it’s specifically trained for financial language. Not cheap (enterprise pricing, typically $15K-$50K+ annually depending on seats and data access), but the quality of signal extraction from earnings calls alone justifies it for funds doing public market research.
Tegus (now part of AlphaSense) — Expert network transcripts with an AI search layer. If you want to understand how former employees of a company actually describe its competitive position, this is a faster path than cold-calling references.
Crunchbase Pro + AI features — For venture investors tracking private markets, Crunchbase’s AI-enhanced search lets you build watchlists, get alerts on funding patterns, and run basic comp analysis. It’s not deep intelligence, but it’s solid first-pass infrastructure. Pro runs around $29-49/month.
CB Insights — Their “Analyst” AI product is positioned for market map generation and sector intelligence. More expensive and enterprise-oriented, but useful for funds that need defensible market sizing and competitive landscape documentation.
A Framework for AI-Assisted Deal Analysis
The investors getting the most out of AI aren’t just prompting randomly. They’ve built repeatable frameworks — essentially structured prompts mapped to their investment thesis. Here’s a practical six-step process that reflects what’s working:
- Intake and structuring. Feed the pitch deck, one-pager, or company website into Claude or GPT-4o. Prompt: “Summarize this company’s core product, target customer, business model, and stated differentiation. Flag anything that’s missing or vague.” This forces structure before opinion.
- Market validation. Run a Perplexity search on the market the company operates in. Ask: who are the established players, what’s the growth trajectory of the category, and are there recent regulatory or macro tailwinds/headwinds? Get cited sources, not just assertions.
- Comp table generation. Prompt GPT-4o or Claude: “Generate a table of the five most comparable companies to [Company X], including their funding stage, last known valuation, core product differentiation, and notable investors.” This isn’t perfect — verify the data — but it gives you a starting scaffold in minutes rather than hours.
- Red flag scan. Explicitly prompt for skepticism: “Based on everything above, what are the five biggest risks or red flags for this company? Consider market timing, competitive dynamics, team gaps, and business model sustainability.” LLMs are better at this than people expect, especially when given permission to be critical.
- Question generation. “Based on your analysis, generate 10 specific due diligence questions the investment team should ask this founder in a first meeting.” These questions often surface assumptions you didn’t know you were making.
- Thesis fit check. Paste in your fund’s stated thesis and ask: “Does this deal fit our investment criteria? Score it 1-10 on each criterion and explain your reasoning.&#